Head-to-head · Value Score
CoreAge Rx vs Ivy Rx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Ivy Rx a 76. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameIvy Rx
#117 · Grade B- · Fair Price
Est. first month
$97/mo intro (4 doses, compounded); list price $197/mo
Save ~87% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 76 — an est. $99/mo first month, with no teaser step-up baked in. Ivy Rx isn't out of it: Someone who wants a microdose or an oral melt rather than a standard weekly injection.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Ivy Rx |
|---|---|---|
| Value Score | 93 (A+) | 76 (B-) |
| Est. first month | $99/mo | $97/mo intro (4 doses, compounded); list price $197/mo |
| Save vs brand-name | ~89% | ~87% |
| Semaglutide | $99/mo | $97/mo intro (4 doses, compounded); list price $197/mo |
| Tirzepatide | $149/mo | From $275/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Ivy Rx
Ivy Rx is a longevity-focused telehealth shop selling compounded GLP-1 injections, a lower-dose microdose version and oral GLP-1 melts, compounded to 503B and USP 797 standards.
Why it's a deal
- Sells three GLP-1 formats rather than one — a standard injection, a lower-dose microdose at $77, and oral melts for anyone avoiding needles
- Names the compounding standard its pharmacies work to, 503B and USP 797, which is the more heavily regulated of the two routes
- Says the medication is independently verified in FDA-registered labs, not just compounded in a licensed one
- The price is on the product page rather than behind the questionnaire
The fine print
- The $97 is an introductory rate struck through against a $197 list price, and the site does not say how many months it holds
- Prices are quoted per four doses rather than per month, so the figure and the billing cycle are not the same unit
- The GLP-1 products are listed as "GLP-1" without naming the molecule on the shop page, so which drug you are buying is not clear until later
- It sits in a longevity catalog alongside NAD+, glutathione and B12 injections, so the weight-loss program is not the main business
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Ivy Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.